CUBE vs PBYI · P/E 25, rev $1.12B vs P/E 4.3, rev $56.5M
CubeSmart (CUBE) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2025-12-31 was $1.12B. Net income was $331.3M. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the CUBE and PBYI stock pages for the full models.
Not investment advice.